Alkyl chlorides
![Medchemexpress LLC 5-[(phenylmethoxy)methyl]-7-(1-pyrrolidinylmethyl)-8-quinolinol | 383392-66-3 | 98.9% | 348.44 | C22H24N2O2 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000264388.png-250.jpg)
Medchemexpress LLC 5-[(phenylmethoxy)methyl]-7-(1-pyrrolidinylmethyl)-8-quinolinol | 383392-66-3 | 98.9% | 348.44 | C22H24N2O2 | 5 MG
UC-112 is a small-molecule inhibitor of inhibitor of apoptosis proteins (IAP) developed for cellular studies of apoptosis and anticancer activity. It produces cytotoxic and antiproliferative effects across multiple human cancer cell lines and is supplied as a solid or as a DMSO solution for research applications.
- Potent IAP inhibitor with reported cell-assay IC50 = 0.7-3.4 μM.
- Demonstrated activity in PC-3, A-375, M14, and DU-145 cell lines.
- High purity (98.92%) suitable for in vitro studies.
- Molecular formula C22H24N2O2; molecular weight 348.44.
- Available as milligram quantities and as a 10 mM solution in DMSO.
- Intended for research use in apoptosis and anticancer mechanism studies.
Cambridge Isotope Laboratories 1-Methylnaphthalene (unlabeled) 200 ug/mL in isooctane 1 2 mL
1-Methylnaphthalene (unlabeled) 200 ug/mL in isooctane 1 2 mL
Matrix Scientific (DIFLUOROMETHYL)BENZENE-1G
(Difluoromethyl)benzene, 97%; 1g,C7H6F2, MFCD03788488, mw 128.12, [455-31-2]
Apexbio Technology LLC I-CBP 112 1640282-31-0 5mg
I-CBP 112 (CAS 1640282-31-0) is a selective small-molecule inhibitor targeting the bromodomains of CREBBP (CBP) and EP300 two epigenetic regulators involved in transcriptional control In biochemical assays I-CBP 112 demonstrates an IC50 of 170 nM against CREBBP with marked selectivity over other bromodomain-containing proteins such as ATAD2 BAZ2B and members of the BET family In vitro studies indicate that I-CBP 112 does not exhibit significant cytotoxicity in U2OS cells at concentrations up to 50 M Currently this compound is utilized predominantly in cellular and molecular studies to dissect the function of CREBBP/EP300 bromodomains in gene regulation with ongoing use limited to preclinical in vitro research contexts
Apexbio Technology LLC I-CBP 112 1640282-31-0 10mg
I-CBP 112 (CAS 1640282-31-0) is a selective small-molecule inhibitor targeting the bromodomains of CREBBP (CBP) and EP300 two epigenetic regulators involved in transcriptional control In biochemical assays I-CBP 112 demonstrates an IC50 of 170 nM against CREBBP with marked selectivity over other bromodomain-containing proteins such as ATAD2 BAZ2B and members of the BET family In vitro studies indicate that I-CBP 112 does not exhibit significant cytotoxicity in U2OS cells at concentrations up to 50 M Currently this compound is utilized predominantly in cellular and molecular studies to dissect the function of CREBBP/EP300 bromodomains in gene regulation with ongoing use limited to preclinical in vitro research contexts
eMolecules Key Organics/BIONET 2 4-dichloro-3-(trifluoromethyl)pyridine 10mg 564136012 HD-0214 97 000 1186194-98-8 MFCD12547046 215 980 C6H2Cl2F3N
Key Organics/BIONET 2 4-dichloro-3-(trifluoromethyl)pyridine 10mg 564136012 HD-0214 97 000 1186194-98-8 MFCD12547046 215 980 C6H2Cl2F3N
Cambridge Isotope Laboratories 1-Methylnaphthalene (D10 98%) 0 1 g
1-Methylnaphthalene (D10 98%) 0 1 g